Recent news and posts
Two new diagnostic codes were added to private reimbursement schedule in England in July/August 2018
30 Oct 2018
The Clinical Coding and Schedule Development (CCSD) develops and maintains procedural and diagnostics nomenclature for private payers in England. Once codes are added to the Schedule, a rivate insurance company can develop reimbursement tariff for these procedures and tests.
The CCSD Group has approved the following diagnostic codes for publication to the CCSD Schedule in July/August with a recommended adoption date of 1st November 2018:
- 18S rRNA gene and Sequencing (3545G)
- ELA2 Cyclic Neutropenia Genetic Screen (3546G)
See full details here.
Subscribe to our newsletter delivered every second week not to miss important reimbursement information.